订阅小程序
旧版功能

Supplementary Data from Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab As Second-line Treatment in Patients with Advanced Gastric Cancer

openalex(2023)

引用 0|浏览0
关键词
Combination Therapies,Adjuvant Therapy,Gastric Cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要